About this Research Topic
MRI-LINAC based radiation treatments are currently being used for selected patient populations and body regions, and knowledge related to the outcomes of this modality is progressing. The outcome and long-term side effects in comparison with other modern LINAC are now being studied. As contouring, planning, quality assessment, and treatment assessment require new techniques for the use of all team members, including technicians, dosimetrists, and physicians, research reporting on these factors and each stage of the process is needed for medical professionals. Furthermore, as physicians report a low incidence of acute side effects, with almost none for long-term follow-up, this knowledge should be published in the radiation milieu.
The goal of this Research Topic is to collect and summarise the growing knowledge from institutions using MRI-LINAC, in order to share the obstacles, solutions, learning curves, and innovations of this new treatment modality.
We welcome Original Research, Reviews, Perspectives, and Methods, related to (but not limited to) the adoption and use of MRI-LINAC for physicians, clinicians, and other associate personnel, short-term studies for specific malignant diseases (prostate, pancreas, lung, etc.), patient-reported outcome measures, safety measures, and multidisciplinary perspectives related to MRI guided radiation therapy.
--
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
The goal of this Research Topic is to collect and summarise the growing knowledge from institutions using MRI-LINAC, in order to share the obstacles, solutions, learning curves, and innovations of this new treatment modality.
We welcome Original Research, Reviews, Perspectives, and Methods, related to (but not limited to) the adoption and use of MRI-LINAC for physicians, clinicians, and other associate personnel, short-term studies for specific malignant diseases (prostate, pancreas, lung, etc.), patient-reported outcome measures, safety measures, and multidisciplinary perspectives related to MRI guided radiation therapy.
--
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Keywords: : MRI guided radiation therapy, MRI-LINAC, SBRT, ASBRT, Prostate cancer, Pancreatic cancer
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
